Wenfang Lai

506 total citations
17 papers, 378 citations indexed

About

Wenfang Lai is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Wenfang Lai has authored 17 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Pharmacology. Recurrent topics in Wenfang Lai's work include Medicinal Plants and Bioactive Compounds (7 papers), Mitochondrial Function and Pathology (3 papers) and Apelin-related biomedical research (3 papers). Wenfang Lai is often cited by papers focused on Medicinal Plants and Bioactive Compounds (7 papers), Mitochondrial Function and Pathology (3 papers) and Apelin-related biomedical research (3 papers). Wenfang Lai collaborates with scholars based in China and New Zealand. Wenfang Lai's co-authors include Guizhu Hong, John Brown, Kedan Chu, Lidian Chen, Yingzheng Wang, Xiaoqin Zhang, Yicong Wei, Meirong Huo, Ping Ma and Tingjie Yin and has published in prestigious journals such as The FASEB Journal, Molecular Endocrinology and European Journal of Medicinal Chemistry.

In The Last Decade

Wenfang Lai

16 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenfang Lai China 9 203 82 51 48 47 17 378
Haitong Wan China 12 249 1.2× 55 0.7× 34 0.7× 51 1.1× 59 1.3× 36 476
Qiyue Yang China 10 145 0.7× 76 0.9× 90 1.8× 57 1.2× 31 0.7× 14 398
Honghe Xiao China 11 165 0.8× 50 0.6× 64 1.3× 51 1.1× 45 1.0× 26 385
Chengli Ling China 8 215 1.1× 95 1.2× 41 0.8× 37 0.8× 107 2.3× 9 439
Meng Gao China 13 214 1.1× 49 0.6× 24 0.5× 62 1.3× 52 1.1× 31 486
Saiprasad Gowrikumar United States 15 331 1.6× 86 1.0× 96 1.9× 48 1.0× 24 0.5× 20 736
Shuai Shao China 15 264 1.3× 41 0.5× 74 1.5× 107 2.2× 36 0.8× 20 513
Wan Gong China 10 234 1.2× 30 0.4× 37 0.7× 41 0.9× 17 0.4× 22 408
Mihong Ren China 10 210 1.0× 127 1.5× 61 1.2× 61 1.3× 12 0.3× 22 456
Jiasi Wu China 14 239 1.2× 28 0.3× 122 2.4× 71 1.5× 31 0.7× 23 526

Countries citing papers authored by Wenfang Lai

Since Specialization
Citations

This map shows the geographic impact of Wenfang Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenfang Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenfang Lai more than expected).

Fields of papers citing papers by Wenfang Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenfang Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenfang Lai. The network helps show where Wenfang Lai may publish in the future.

Co-authorship network of co-authors of Wenfang Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Wenfang Lai. A scholar is included among the top collaborators of Wenfang Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenfang Lai. Wenfang Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lai, Wenfang, Jia Nie, Tao Zhang, et al.. (2025). Neuroprotective effects of Rosavin via HIF-1α signaling in a rat model of ischemic stroke. Phytomedicine. 145. 157068–157068.
2.
Zhang, Yan, Jianan Zhang, Wenfang Lai, et al.. (2025). Integrated transcriptomics and metabolomics unravel the key metabolic pathways involved in the therapeutic mechanism of Salvianic acid A against hepatic fibrosis. Toxicology and Applied Pharmacology. 500. 117398–117398. 2 indexed citations
4.
Lai, Wenfang, Yanfeng He, Qingqing Wu, et al.. (2024). Salidroside facilitates neuroprotective effects in ischemic stroke by promoting axonal sprouting through promoting autophagy. Phytomedicine. 135. 156208–156208. 7 indexed citations
5.
Zhang, Ying, et al.. (2024). Oxysophoridine inhibits oxidative stress and inflammation in hepatic fibrosis via regulating Nrf2 and NF-κB pathways. Phytomedicine. 132. 155585–155585. 13 indexed citations
6.
Lai, Wenfang, et al.. (2024). Salidroside directly activates HSC70, revealing a new role for HSC70 in BDNF signalling and neurogenesis after cerebral ischemia. Phytotherapy Research. 38(6). 2619–2640. 5 indexed citations
7.
Chen, Yaping, Zheming Chen, Yajun Cao, et al.. (2022). The Role of the GRP78/PERK/ATF4 Pathway in the Ability of Gua Lou Gui Zhi Decoction to Attenuate Apoptosis by Inhibiting Endoplasmic Reticulum Stress after Ischemia-Reperfusion Injury. Frontiers in Bioscience-Landmark. 27(10). 296–296. 6 indexed citations
8.
Ye, Miao, Wen Xu, Wenfang Lai, et al.. (2020). Dammarane-Type Triterpenoids from the Roots of Rhus chinensis and Their Preventive Effects on Zebrafish Heart Failure and Thrombosis. Journal of Natural Products. 83(2). 362–373. 14 indexed citations
9.
Yang, Zelin, Wenfang Lai, Yingzheng Wang, et al.. (2020). Synthesis and identification of a novel derivative of salidroside as a selective, competitive inhibitor of monoamine oxidase B with enhanced neuroprotective properties. European Journal of Medicinal Chemistry. 209. 112935–112935. 24 indexed citations
10.
Xie, Qingqing, Zheming Chen, Yuqin Zhang, et al.. (2019). Involvement of PARP-1/AIF Signaling Pathway in Protective Effects of Gualou Guizhi Decoction Against Ischemia–Reperfusion Injury-Induced Apoptosis. Neurochemical Research. 45(2). 278–294. 19 indexed citations
11.
Yin, Tingjie, et al.. (2018). Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment. International Journal of Nanomedicine. Volume 13. 1585–1600. 81 indexed citations
12.
Lai, Wenfang, Xiaoqin Zhang, Yingzheng Wang, et al.. (2017). Inhibition of Complement Drives Increase in Early Growth Response Proteins and Neuroprotection Mediated by Salidroside After Cerebral Ischemia. Inflammation. 41(2). 449–463. 29 indexed citations
13.
Wei, Yicong, Xiaoqin Zhang, Wenfang Lai, et al.. (2017). Salidroside Inhibits Inflammation Through PI3K/Akt/HIF Signaling After Focal Cerebral Ischemia in Rats. Inflammation. 40(4). 1297–1309. 84 indexed citations
14.
Lai, Wenfang, Ru Jia, Yanfang Zheng, et al.. (2017). Impacts of the serum containing total flavonoids of Ajuga on rat glomerular mesangial cells. Molecular Medicine Reports. 16(4). 4895–4902. 3 indexed citations
15.
Lai, Wenfang, Xiaoqin Zhang, Yicong Wei, et al.. (2015). Salidroside-Mediated Neuroprotection is Associated with Induction of Early Growth Response Genes (Egrs) Across a Wide Therapeutic Window. Neurotoxicity Research. 28(2). 108–121. 30 indexed citations
16.
Lai, Wenfang, Tian Xue, Qing Xiang, et al.. (2015). 11β-HSD1 Modulates LPS-Induced Innate Immune Responses in Adipocytes by Altering Expression of PTEN. Molecular Endocrinology. 29(4). 558–570. 6 indexed citations
17.
Zheng, Yanfang, et al.. (2014). The laxative effect of emodin is attributable to increased aquaporin 3 expression in the colon of mice and HT-29 cells. Fitoterapia. 96. 25–32. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026